HOME >> BIOLOGY >> NEWS
Findings link disease specific anitbodies to activation of T cells for the first time

Torrance, Calif. (January 25, 2002) - Harbor-UCLA Research & Education Institute (REI) announced new findings indicating that antibodies specific to Graves disease bind to cell surface receptors. These are distinct from thyroid-stimulating hormone (TSH) receptors. This interaction leads to activation of key genes and T cell activation. It is believed that antibody/receptor complex initiates a cascade of events culminating in T cell activities and thyroid growth. This research, conducted by principal REI investigator Terry J. Smith, MD and collaborators at Boston University School of Medicine, Boston was published recently in The Journal of Immunology, 168:942-950,2002.

What is exciting about these findings is that now, for the first time, we can tie together pathogenic antibodies in Graves disease with T cell activation, said Dr. Smith, Chief, Division of Molecular Medicine, Department of Medicine at Harbor-UCLA Medical Center. This holds promise for future research to learn how to turn off the expression, thereby eradicating the disease state. Graves disease is often associated with profound metabolic derangements and potentially site-threatening changes in the tissues around the eye, he added.

Dr. Smith and his collaborator, William Cruikshank, PhD at Boston University School of Medicine have been studying the pathogenesis of inflammation associated with many conditions, including rheumatoid arthritis, Graves disease, and lupus. This research group has recently identified a number of potential pathways that may be utilized by lymphocyte derived cytokines in driving the tissue remodeling that occurs in Graves disease. Dr. Smith and his associates have found that fibroblasts from the orbital connective tissue (eye area) differ from fibroblasts found in other parts of the body. The orbital fibroblasts appear to be particularly susceptible to inflammatory reactions. Fibroblasts are highly specialized cells and react differentl
'"/>

Contact: Barbara T. Kerr
bkerr@rei.edu
310-222-2820
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
24-Jan-2002


Page: 1 2

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings offer further understanding about growth and development in young male gymnasts
7. Findings in frog oocytes may help study of chromosome physiology
8. Findings aid understanding of neurodegenerative diseases
9. Findings show exceptional longevity runs in families
10. Findings give insight into how colon cells transform into precancerous polyps
11. Findings conclude sustained caffeine intake negates the benefits of creatine supplements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2019)... ... 25, 2019 , ... Researchers have found multiple applications for ... came into use by the scientific community. Keck Graduate Institute (KGI) Assistant Professor ... combine the power of CRISPR’s nucleic acid targeting with the ultra sensitivity of ...
(Date:3/18/2019)... SAN DIEGO (PRWEB) , ... March 18, 2019 , ... ... lead to tooth loss, affects nearly 50% of the US population. Making this ... surfaces in a biofilm state, where the cells are enmeshed in a sticky extracellular ...
(Date:3/14/2019)... ... March 13, 2019 , ... Bode Technology (Bode), a leading provider of ... more than 100,000 sexual assault kits. As thousands of untested kits are identified across ... assault kit backlogs . Bode has tested more than 50,000 kits in the last ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... Xybion ... research organizations. It is a low code, GDPR/21 CFR Part 11-compliant digital ... technology-driven automated data capture and seamless data and information management. , ...
(Date:3/11/2019)... Calif. (PRWEB) , ... March 11, 2019 , ... ... solution for enterprise content and information management with built in GxP compliance for the ... Generis customers to manage GxP validation and continuous compliance for Generis’ flagship ...
(Date:3/5/2019)... HOUSTON Texas (PRWEB) , ... March 05, 2019 ... ... is a biopharmaceutical cold chain engineering firm with regulatory filing authorities, logistics network ... corporate information to initiate its participation in the Inc. Verified Profile program, ...
(Date:2/26/2019)... , ... February 26, 2019 , ... ... when Visikol Co-Founder Dr. Thomas Villani developed the Visikol® tissue clearing technology for ... has since transitioned from a products focused company to primarily a services focused ...
Breaking Biology Technology:
Cached News: